Chemoinformaics analysis of (E)-13-CYCLOPENT-2-EN-1-YLTRIDEC-6-ENOIC ACID
| Molecular Weight | 278.436 | nRot | 12 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 13 |
| Exact Molecular Weight | 278.225 | nRing | 1 |
| Solubility: LogS | -0.972 | nHRing | 0 |
| Solubility: LogP | -0.838 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 51.6678 |
| nHD | 1 | BPOL | 30.9642 |
| QED | 0.456 |
| Synth | 3.655 |
| Natural Product Likeliness | 1.947 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.136 |
| HIA | 0.897 |
| CACO-2 | -5.403 |
| MDCK | 0.000283565 |
| BBB | 0.715 |
| PPB | 0.746939 |
| VDSS | 0.59 |
| FU | 0.338192 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.11 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.352 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.543 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.319 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.032 |
| CL | 1.904 |
| T12 | 0.727 |
| hERG | 0.054 |
| Ames | 0.327 |
| ROA | 0.196 |
| SkinSen | 0.303 |
| Carcinogencity | 0.369 |
| EI | 0.012 |
| Respiratory | 0.149 |
| NR-Aromatase | 0.098 |
| Antiviral | Yes |
| Prediction | 0.64116 |